Inactive Instrument
Calliditas Therapeutics AB Share Price
Stocks
0A5R
SE0010441584
Pharmaceuticals
OTC Markets Traded| 1 day | +0.98% |
| Manager | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | 49 | 31/07/2017 | |
Lars Stubberud
CTO | Chief Tech/Sci/R&D Officer | 62 | 31/12/2023 |
| Chief Tech/Sci/R&D Officer | - | 28/02/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Hensley
CHM | Chairman | 43 | - |
Yoshikazu Aoki
BRD | Director/Board Member | - | - |
Masaya Etoh
BRD | Director/Board Member | - | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 04/09/24 | Sell | Chairman | 56,860 | 0.0954% | ||
| 04/09/24 | Sell | Chief Financial Officer | 10,000 | 0.0168% | ||
| 04/09/24 | Sell | 13,535 | 0.0227% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.98% | -0.19% | - | - | 1.16B | |
| +3.19% | +11.31% | +67.86% | +150.58% | 1,263B | |
| -0.73% | +3.56% | +44.51% | +85.81% | 658B | |
| +1.41% | +3.24% | +29.22% | +107.83% | 521B | |
| +0.42% | +3.20% | +54.15% | +67.18% | 391B | |
| +2.18% | +2.93% | +73.30% | +45.62% | 369B | |
| +1.12% | +4.52% | +35.30% | +58.08% | 307B | |
| +6.96% | +8.86% | +11.27% | +36.62% | 290B | |
| +1.15% | +6.09% | +59.59% | +77.06% | 252B | |
| +3.06% | +9.38% | +44.11% | +119.47% | 212B | |
| Average | +1.65% | +5.61% | +46.59% | +83.14% | 473.55B | |
| Weighted average by Cap. | +1.19% | +6.39% | +50.88% | +98.31% |
Employees
222
Sector
Pharmaceuticals
